CHROMagar candida medium for direct susceptibility testing of yeast from blood cultures

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 1727-1731

  Tan, Grace L ^a   Peterson, Ellena M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DYE; FLUCONAZOLE; GLUCOSE; METHYLENE BLUE;

ARTICLE; BLOOD CULTURE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DILUTION; DRUG SENSITIVITY; GRAM STAINING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

AGAR; ANTIFUNGAL AGENTS; BLOOD; CANDIDA; CANDIDIASIS; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; FLUCONAZOLE; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 16844373192     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.1727-1731.2005     Document Type: Article

References (8)

1. Antoniadou, A., H. A. Torres, R. E. Lewis, J. Thornby, G. P. Bodey, J. P. Tarrand, X. Y. Han, K. V. Rolston, A. Safdar, I. I. Raad, and D. P. Kontoyiannis. 2003. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine 82:309-321.
2. Espinel-Ingroff, A., M. Pfaller, S. A. Medsser, C. C. Knapp, S. Killian, H. A. Norris, and M. A. Ghannoum. 1999. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J. Clin. Microbiol. 37:591-595.
3. Hazen, K., and S. A. Howell. 2003. Candida, Cryptococcus, and other yeasts of medical importance, p. 1693-1711. In P. M. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
4. Horvath, L. L., D. R. Hospenthal, C. K. Murray, and D. P. Dooley. 2003. Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J. Clin. Microbiol. 41:2629-2632.
5. Hospenthal, D. R., C. K. Murray, and M. G. Rinaldi. 2004. The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn. Microbiol. Infect. Dis. 48:153-160.
6. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disk diffusion susceptibility testing of yeasts: proposed guideline M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Pfaller, M. A., D. J. Diekema, L. Boyken, S. A. Messer, S. Tendolkar, and R. J. Hollis. 2003. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J. Clin. Microbiol. 41:1875-1880.